Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | LVTX |
---|---|---|
09:32 ET | 4709 | 2.3 |
09:34 ET | 602 | 2.43 |
09:36 ET | 100 | 2.31 |
09:38 ET | 200 | 2.29 |
09:39 ET | 2101 | 2.43 |
09:41 ET | 800 | 2.375 |
09:43 ET | 1400 | 2.44 |
09:45 ET | 1000 | 2.37 |
09:48 ET | 5250 | 2.53 |
09:50 ET | 1456 | 2.51 |
09:54 ET | 100 | 2.33 |
09:56 ET | 100 | 2.42 |
09:57 ET | 100 | 2.33 |
09:59 ET | 1870 | 2.42 |
10:01 ET | 601 | 2.5 |
10:03 ET | 14268 | 2.445 |
10:06 ET | 300 | 2.4747 |
10:08 ET | 200 | 2.4739 |
10:14 ET | 2000 | 2.4 |
10:17 ET | 100 | 2.46 |
10:19 ET | 310 | 2.4543 |
10:21 ET | 1000 | 2.43 |
10:33 ET | 279 | 2.434 |
10:44 ET | 300 | 2.45 |
10:51 ET | 400 | 2.45 |
10:53 ET | 700 | 2.47 |
11:00 ET | 4058 | 2.37 |
11:11 ET | 100 | 2.415 |
11:24 ET | 200 | 2.46 |
11:42 ET | 3502 | 2.36 |
11:44 ET | 1895 | 2.36 |
11:58 ET | 200 | 2.41 |
12:21 ET | 100 | 2.43 |
12:27 ET | 200 | 2.42 |
01:10 ET | 200 | 2.4 |
01:12 ET | 100 | 2.39 |
01:14 ET | 100 | 2.38 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
LAVA Therapeutics NV | 59.4M | -2.2x | --- |
Kezar Life Sciences Inc | 50.5M | -0.5x | --- |
BioLine RX Ltd | 58.4M | -1.0x | --- |
Kronos Bio Inc | 47.5M | -0.4x | --- |
DURECT Corp | 53.1M | -1.9x | --- |
Atara Biotherapeutics Inc | 67.5M | -0.3x | --- |
LAVA Therapeutics NV, formerly known as Lava Therapeutics BV, is a provider of biotechnology research and development services based in the Netherlands. The Company focuses of developing next generation Vdelta T cell engaging bispecific antibodies to fight cancer.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $59.4M |
---|---|
Revenue (TTM) | $12.5M |
Shares Outstanding | 26.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-1.07 |
Book Value | $1.95 |
P/E Ratio | -2.2x |
Price/Sales (TTM) | 4.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -252.58% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.